Elevance Health Inc.

(New York Stock Exchange)
Back to all articles
Somewhat Bullish +45

ELV Dividend History: 1.68% Yield Β· $1.72 quarterly | MerryDiv

AI-generated analysis

πŸ“ˆ Elevance Health Inc. (ELV) pays a $6.86 annual dividend ($1.72 quarterly) with a current yield of 1.68% at a share price of $407.50.

πŸ“… The next ex-dividend date for ELV is set for September 10, 2026.

πŸ“Š ELV has achieved 13 consecutive years of dividend growth with a CAGR of 14.7% from 2011 to 2025.

πŸ›‘οΈ The company maintains a conservative payout ratio of 30.4%, distributing less than 40% of earnings to support dividend safety.

πŸ₯ ELV serves approximately 118 million individuals across medical, pharmaceutical, behavioral health, and digital care solutions.

πŸ“‰ The stock has a beta of 0.696, indicating below-market price volatility suitable for risk-averse investors.

πŸ”„ Elevance Health Inc. rebranded from Anthem, Inc. to its current name in June 2022 while retaining its Indianapolis headquarters.

Bullish Signals
  • Elevance Health Inc. has increased its dividend for 13 consecutive years, demonstrating a strong commitment to returning capital to shareholders.
  • The company maintains a conservative payout ratio of 30.4%, providing ample financial cushion to sustain or grow the dividend even if earnings decline.
  • ELV serves a massive scale of approximately 118 million people, creating broad and stable demand for its health benefits services.
Risk Factors
  • The current dividend yield of 1.68% is relatively low compared to high-yield alternatives, potentially limiting immediate income appeal for some investors.
Full Analysis
Elevance Health Inc. (ELV) is a major health benefits organization serving approximately 118 million people across medical, pharmaceutical, behavioral health, and digital care solutions. Founded in 1944 and formerly known as Anthem, the company adopted its current name in June 2022. Based in Indianapolis, Indiana, ELV operates with a beta of 0.696, indicating below-market price volatility that appeals to investors seeking stability. The company pays an annual dividend of $6.86 per share ($1.72 quarterly), resulting in a current yield of 1.68% at a stock price of $407.50. The next ex-dividend date is scheduled for September 10, 2026. ELV has demonstrated a strong track record with 13 consecutive years of dividend increases and a compound annual growth rate (CAGR) of 14.7% from 2011 to 2025. Financially, Elevance Health maintains a conservative payout ratio of 30.4%, meaning it distributes only about one-third of its earnings as dividends. This low payout ratio provides substantial room to sustain or grow the dividend even if earnings face pressure. However, the current yield remains relatively low compared to high-yield alternatives, positioning ELV primarily for growth-and-income investors rather than those seeking immediate high income.